<DOC>
	<DOCNO>NCT01516606</DOCNO>
	<brief_summary>This prospective , phase II study activity tolerability high dose ( 2 g/day ) oral clarithromycin treatment relapse refractory extranodal marginal zone lymphoma .</brief_summary>
	<brief_title>Salvage Therapy With High Dose Oral Clarithromycin Relapsed Refractory Extranodal Marginal Zone Lymphoma</brief_title>
	<detailed_description>A 6-month regimen oral clarithromycin associate 35 % ORR patient relapsed/refractory marginal zone B-cell lymphoma . Responses common among patient conjunctival lymphoma . This could explain least part elimination clarithromycin tear , suggest high tumor bioavailability antibiotic could result high activity . Thus , high dose clarithromycin could associate high tumor bioavailability tissue conjunctiva .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , B-Cell , Marginal Zone</mesh_term>
	<mesh_term>Lymphoma , B-Cell</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<criteria>histologically confirm diagnosis extranodal extragastric marginal zone cell B lymphoma gastric Helicobacter pylori positive lymphoma refractory conventional antibiotic therapy , H. pylorus negative least one measurable lesion relapse refractory lymphoma systemic ( chemotherapy , immunotherapy , antibiotic ) local ( surgery radiation ) therapy ECOG PS &lt; /= 3 prior antibiotic therapy within 3 month enrollment HIV 12 infection concomitant conventional experimental antitumor therapy ( chemotherapy , radiotherapy , immunotherapy , corticosteroid ) severe inadequate liver ( AST &lt; /=3 ULN , ALT &lt; /= 3 ULN , bilirubin &lt; /=3 ULN ) renal ( creatinine &lt; /= 1.5 ULN ) function allergy macrolides concomitant malignant neoplasm within prior 5 year ( exclusion basal cell carcinoma , situ spinocellular carcinoma skin cervix )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>MALT</keyword>
	<keyword>refractory</keyword>
	<keyword>relapse</keyword>
	<keyword>extranodal</keyword>
	<keyword>relapsed refractory extranodal marginal zone lymphoma</keyword>
</DOC>